Literature DB >> 19002431

Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia.

A L Gloyn, M van de Bunt, I M Stratton, L Lonie, L Tucker, S Ellard, R R Holman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19002431     DOI： 10.1007/s00125-008-1188-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

Review 1.  Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics.

Authors:  Franz M Matschinsky
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

2.  Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents.

Authors:  E Feigerlová; S Pruhová; L Dittertová; J Lebl; D Pinterová; K Kolostová; M Cerná; O Pedersen; T Hansen
Journal:  Eur J Pediatr       Date:  2006-04-07       Impact factor: 3.183

3.  The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.

Authors:  S Karunakaran; M S Hammersley; R J Morris; R C Turner; R R Holman
Journal:  Metabolism       Date:  1997-12       Impact factor: 8.694

4.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

Review 5.  Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.

Authors:  Anna L Gloyn
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

6.  High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.

Authors:  O Massa; F Meschi; A Cuesta-Munoz; A Caumo; F Cerutti; S Toni; V Cherubini; L Guazzarotti; N Sulli; F M Matschinsky; R Lorini; D Iafusco; F Barbetti
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

7.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.

Authors:  S Ellard; C Bellanné-Chantelot; A T Hattersley
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122
  7 in total
  15 in total

1.  GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated.

Authors:  David Carmody; Rochelle N Naylor; Charles D Bell; Shivani Berry; Jazzmyne T Montgomery; Elizabeth C Tadie; Jessica L Hwang; Siri Atma W Greeley; Louis H Philipson
Journal:  Acta Diabetol       Date:  2016-04-22       Impact factor: 4.280

Review 2.  Glucokinase MODY and implications for treatment goals of common forms of diabetes.

Authors:  Ramzi A Ajjan; Katharine R Owen
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

3.  Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism.

Authors:  James T Bennett; Valeria Vasta; Min Zhang; Jaya Narayanan; Peter Gerrits; Si Houn Hahn
Journal:  Mol Genet Metab       Date:  2014-12-20       Impact factor: 4.797

4.  Frequency and spectrum of glucokinase mutations in an adult Maltese population.

Authors:  Nikolai Paul Pace; Celine Ann Grech; Barbara Vella; Ruth Caruana; Josanne Vassallo
Journal:  Acta Diabetol       Date:  2021-10-22       Impact factor: 4.280

5.  Hepatopancreatic intoxication of lambda cyhalothrin insecticide on albino rats.

Authors:  Manal Ea Elhalwagy; Sherif H Abd-Alrahman; A A Nahas; Reem M Ziada; Aziza H Mohamady
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 6.  Interactions between genetic background, insulin resistance and β-cell function.

Authors:  S E Kahn; S Suvag; L A Wright; K M Utzschneider
Journal:  Diabetes Obes Metab       Date:  2012-10       Impact factor: 6.577

7.  Hepatic glucose sensing is impaired, but can be normalized, in people with impaired fasting glucose.

Authors:  Leigh Perreault; Kristine Færch; Anna A Kerege; Samantha D Bacon; Bryan C Bergman
Journal:  J Clin Endocrinol Metab       Date:  2014-04-14       Impact factor: 5.958

8.  Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.

Authors:  Anna M Steele; Kirsty J Wensley; Sian Ellard; Rinki Murphy; Maggie Shepherd; Kevin Colclough; Andrew T Hattersley; Beverley M Shields
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

9.  Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Authors:  Aparna Pal; Andrew J Farmer; Christina Dudley; Mary P Selwood; Beryl A Barrow; Rhiannon Klyne; Jilly P Grew; Mark I McCarthy; Anna L Gloyn; Katharine R Owen
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

Review 10.  Clinical implications of the glucokinase impaired function - GCK MODY today.

Authors:  J Hulín; M Škopková; T Valkovičová; S Mikulajová; M Rosoľanková; P Papcun; D Gašperíková; J Staník
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.